ウイルスベクターおよびプラスミドDNAの世界市場レポート 2024

ウイルスベクターおよびプラスミドDNAの市場規模は、今後数年間で急速に成長すると予想されます。 2028年には8.4%の年間複合成長率（CAGR）で16億6,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、この分野における新たな治療応用、遺伝子治療の開発を加速させたCOVID-19パンデミックへの対応、これらの進歩に捧げられた資金の増加、これらの技術の利用における世界的な拡大からもたらされると予想されます。

がん症例の世界の急増は、ウイルスベクターおよびプラスミドDNA市場の成長の重要な原動力となっています。肥満、喫煙、飲酒、不適切な食習慣などの一般的ながんの引き金は、がん診断の大部分に寄与しています。 2022年 1月に米国がん協会が予測したように、米国では同年に190万人の新たながん症例と約609,360人のがん関連死亡が発生する可能性があります。世界的には、肺がん、前立腺がん、腸がん、および女性の乳がんが最も蔓延しており、新規がん症例全体の43%を占めています。このがん発生率の増加により、市場でのウイルスベクターおよびプラスミドDNAの需要が高まると予想されます。

結核の有病率の増加も、ウイルスベクターおよびプラスミドDNA市場の成長を促進しています。結核は細菌によって引き起こされる感染症で、主に肺に影響を与えますが、体の他の部分にも広がる可能性があります。結核の微生物抗原をコードする遺伝子を送達するプラスミド DNAワクチンは、この病気と戦うのに有望であることが示されています。これらのワクチンは、筋肉内注射によって原因菌である結核菌の特異的抗原を発現させることができます。米国疾病管理予防センターの2023年3月の報告書によると、米国では結核症例数が2021年の7,874人から2022年には8,300人に増加しており、ウイルスベクターおよびプラスミドDNA市場の成長における結核症例の原動力が強調されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のウイルスベクターおよびプラスミドDNA市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• プラスミドDNA
• ウイルスベクター
• 世界のウイルスベクターおよびプラスミドDNA市場、疾患別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 感染症
• 遺伝性疾患
• がん
• その他の病気
• 世界のウイルスベクターおよびプラスミドDNA市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 遺伝子治療とがん治療
• ウイルス感染症
• 免疫療法
• 製剤開発
• その他の用途
• 世界のウイルスベクターおよびプラスミドDNA市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 研究機関
• バイオ医薬品および製薬会社

第7章 地域および国の分析

• 世界のウイルスベクターおよびプラスミドDNA市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界のウイルスベクターおよびプラスミドDNA市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ウイルスベクターおよびプラスミドDNA市場の競合情勢
• ウイルスベクターおよびプラスミドDNA市場の企業プロファイル
  • FUJIFILM Diosynth Biotechnologies
  • FinVector Vision Therapies
  • Lonza Group AG
  • Cobra Biologics and Pharmaceutical Services
  • Brammer Bio

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

Viral vectors are tools constructed from viral genomes adapted into plasmid-based technologies. They are modified for safety by removing specific essential genes and separating viral components. On the other hand, plasmid DNA refers to small, circular DNA molecules present in certain bacteria and other microorganisms. These plasmids are physically distinct from chromosomal DNA and can replicate independently.

The primary product types within the viral vectors & plasmid DNA domain include plasmid DNA and viral vectors. Plasmids are circular DNA molecules separate from a cell's chromosomal DNA, commonly found in bacterial and some eukaryotic cells. Plasmid genes often confer genetic advantages to bacteria, such as antibiotic resistance.

The viral vectors & plasmid DNA market research report is one of a series of new reports from The Business Research Company that provides viral vectors & plasmid DNA market statistics, including viral vectors & plasmid DNA industry global market size, regional shares, competitors with a viral vectors & plasmid DNA market share, detailed viral vectors & plasmid DNA market segments, market trends and opportunities, and any further data you may need to thrive in the viral vectors & plasmid DNA industry. This viral vectors & plasmid DNA market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The viral vectors and plasmid dna market size has grown rapidly in recent years. It will grow from $1.05 billion in 2023 to $1.2 billion in 2024 at a compound annual growth rate (CAGR) of 14.8%. The growth observed in the historic period can be attributed to several factors, including the rising prevalence of cancer, a growing awareness and acceptance of gene therapy, an expanding patient population, increased accessibility to healthcare services, and an increasing demand for personalized medicine tailored to individual patients' needs.

The viral vectors and plasmid dna market size is expected to see rapidly grown in the next few years. It will grow to $1.66 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%. The anticipated growth in the forecast period is expected to stem from emerging therapeutic applications in the field, the response to the COVID-19 pandemic which accelerated developments in genetic therapies, a rise in funding dedicated to these advancements, and a global expansion in the utilization of these technologies.

The global surge in cancer cases is a significant driving force behind the growth of the viral vector and plasmid DNA market. Common cancer triggers like obesity, smoking, alcohol consumption, and poor dietary habits contribute to the majority of cancer diagnoses. As projected by the American Cancer Society in January 2022, the US will likely witness 1.9 million new cancer cases and approximately 609,360 cancer-related deaths in the same year. Globally, lung, prostate, bowel, and female breast cancers are the most prevalent, accounting for 43% of all new cancer cases. This rise in cancer incidence is anticipated to bolster the demand for viral vectors and plasmid DNA in the market.

The increasing prevalence of tuberculosis cases is also driving growth in the viral vector and plasmid DNA market. Tuberculosis, an infectious disease caused by bacteria, primarily affects the lungs but can extend to other body parts. Plasmid DNA vaccines, delivering microbial antigen-coding genes for tuberculosis, have shown promise in combating this disease. These vaccines can express specific antigens of Mycobacterium tuberculosis, the causative bacterium, through intramuscular injection. According to the Centers for Disease Control and Prevention's March 2023 report, the US witnessed a rise in tuberculosis cases from 7,874 in 2021 to 8,300 in 2022, emphasizing the driving force of tuberculosis cases in the growth of the viral vector and plasmid DNA market.

Companies in the viral vectors and plasmid DNA market are strategically launching viral vector assays to invigorate gene therapy research. Viral vectors, essential in delivering genetic material into cells, are complemented by viral vector assays, investigative procedures that analyze these vectors. For instance, in November 2022, PerkinElmer introduced 'ready-to-use' adeno-associated virus vectors (AAV) detection kits. These aids support researchers involved in gene therapy across diverse diseases by facilitating the quick and efficient characterization of viral vector particles, guiding safe and effective gene transfer decisions.

Major players in the viral vectors and plasmid DNA market are intensifying their efforts toward product innovation, notably helper plasmids, to gain a competitive edge. Helper plasmids, a form of plasmid DNA utilized in producing viral vectors like adeno-associated viral vectors (AAV), are pivotal in gene therapy. For instance, Charles River Laboratories International Inc. unveiled off-the-shelf pHelper in March 2023. This innovation streamlines the process of developing adeno-associated virus (AAV)-based gene therapy programs, minimizing complexities and expediting supply chains. pHelper, part of a comprehensive line of contract development and manufacturing organization (CDMO) offerings, serves to fortify viral vector packaging in cell and gene therapy endeavors, particularly in creating adeno-associated viral vectors essential for gene therapy.

In January 2023, Moderna Inc., a pharmaceutical and biotechnology company based in the US, finalized the acquisition of OriCiro Genomics for $85 million. This strategic acquisition aims to expedite Moderna's pipeline development by enhancing their capabilities in plasmid DNA synthesis and amplification, which serves as a crucial foundation for manufacturing messenger RNA (mRNA). OriCiro Genomics, a Japan-based genome technology company, specializes in developing and commercializing cell-free systems designed for assembling and amplifying circular DNA molecules, notably plasmids and viral vectors. This acquisition positions Moderna to strengthen its mRNA production processes with advanced tools provided by OriCiro Genomics.

Major companies operating in the viral vectors and plasmid dna market include FUJIFILM Diosynth Biotechnologies, FinVector Vision Therapies, Lonza Group AG, Cobra Biologics and Pharmaceutical Services, Brammer Bio, Kaneka Corporation, Cell and Gene Therapy Catapult, VGXI Inc., MassBiologics, Sanofi, Spark Therapeutics, UniQure NV, Thermo Fisher Scientific, VIROVEK, SIRION Biotech GmbH, ALDEVRON, Oxford BioMedica, PlasmidFactory GmbH & Co. KG, Biovian Oy, BioReliance Corporation, 4D Molecular Therapeutics, Renova Therapeutics, Shenzhen SiBiono GeneTech Co., Vigene Biosciences Inc., Novasep, Genzyme Corporation, Oxford Gene Technology, Richter-Helm, Mylan NV, MolMed, Merck KGaA Inc., Catalent Inc., WuXi AppTec, GenScript Biotech Corporation, Eurogentec, Creative Biogene

North America was the largest region in the viral vectors and plasmid DNA market in 2023. The Middle East is expected to be the fastest growing region in the global viral vectors & plasmid DNA market analysis. The regions covered in the viral vectors and plasmid dna market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the viral vectors and plasmid dna market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The viral vectors and plasmid DNA market consists of sales of adeno-associated viral, adenoviral, lentiviral, and retroviral. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Viral Vectors And Plasmid DNA Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on viral vectors and plasmid dna market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for viral vectors and plasmid dna? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The viral vectors and plasmid dna market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Product: Plasmid DNA; Viral Vectors
• 2) By Disease: Infectious Diseases; Genetic Disorders; Cancer; Other Diseases
• 3) By Application: Gene And Cancer Therapies; Viral Infections; Immunotherapy; Formulation Development; Other Applications
• 4) By End User: Research Institutes; Biopharmaceutical And Pharmaceutical Companies
• Companies Mentioned: FUJIFILM Diosynth Biotechnologies; FinVector Vision Therapies; Lonza Group AG; Cobra Biologics and Pharmaceutical Services; Brammer Bio
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Viral Vectors And Plasmid DNA Market Characteristics

3. Viral Vectors And Plasmid DNA Market Trends And Strategies

4. Viral Vectors And Plasmid DNA Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Viral Vectors And Plasmid DNA Market Size and Growth

• 5.1. Global Viral Vectors And Plasmid DNA Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Viral Vectors And Plasmid DNA Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Viral Vectors And Plasmid DNA Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Viral Vectors And Plasmid DNA Market Segmentation

• 6.1. Global Viral Vectors And Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Plasmid DNA
• Viral Vectors
• 6.2. Global Viral Vectors And Plasmid DNA Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Infectious Diseases
• Genetic Disorders
• Cancer
• Other Diseases
• 6.3. Global Viral Vectors And Plasmid DNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Gene And Cancer Therapies
• Viral Infections
• Immunotherapy
• Formulation Development
• Other Applications
• 6.4. Global Viral Vectors And Plasmid DNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Research Institutes
• Biopharmaceutical And Pharmaceutical Companies

7. Viral Vectors And Plasmid DNA Market Regional And Country Analysis

• 7.1. Global Viral Vectors And Plasmid DNA Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Viral Vectors And Plasmid DNA Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Viral Vectors And Plasmid DNA Market

• 8.1. Asia-Pacific Viral Vectors And Plasmid DNA Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Viral Vectors And Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Viral Vectors And Plasmid DNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Viral Vectors And Plasmid DNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Viral Vectors And Plasmid DNA Market

• 9.1. China Viral Vectors And Plasmid DNA Market Overview
• 9.2. China Viral Vectors And Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Viral Vectors And Plasmid DNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Viral Vectors And Plasmid DNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Viral Vectors And Plasmid DNA Market

• 10.1. India Viral Vectors And Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Viral Vectors And Plasmid DNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Viral Vectors And Plasmid DNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Viral Vectors And Plasmid DNA Market

• 11.1. Japan Viral Vectors And Plasmid DNA Market Overview
• 11.2. Japan Viral Vectors And Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Viral Vectors And Plasmid DNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Viral Vectors And Plasmid DNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Viral Vectors And Plasmid DNA Market

• 12.1. Australia Viral Vectors And Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Viral Vectors And Plasmid DNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Viral Vectors And Plasmid DNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Viral Vectors And Plasmid DNA Market

• 13.1. Indonesia Viral Vectors And Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Viral Vectors And Plasmid DNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Viral Vectors And Plasmid DNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Viral Vectors And Plasmid DNA Market

• 14.1. South Korea Viral Vectors And Plasmid DNA Market Overview
• 14.2. South Korea Viral Vectors And Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Viral Vectors And Plasmid DNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Viral Vectors And Plasmid DNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Viral Vectors And Plasmid DNA Market

• 15.1. Western Europe Viral Vectors And Plasmid DNA Market Overview
• 15.2. Western Europe Viral Vectors And Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Viral Vectors And Plasmid DNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Viral Vectors And Plasmid DNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Viral Vectors And Plasmid DNA Market

• 16.1. UK Viral Vectors And Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Viral Vectors And Plasmid DNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Viral Vectors And Plasmid DNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Viral Vectors And Plasmid DNA Market

• 17.1. Germany Viral Vectors And Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Viral Vectors And Plasmid DNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Viral Vectors And Plasmid DNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Viral Vectors And Plasmid DNA Market

• 18.1. France Viral Vectors And Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Viral Vectors And Plasmid DNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Viral Vectors And Plasmid DNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Viral Vectors And Plasmid DNA Market

• 19.1. Italy Viral Vectors And Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Viral Vectors And Plasmid DNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Viral Vectors And Plasmid DNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Viral Vectors And Plasmid DNA Market

• 20.1. Spain Viral Vectors And Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Viral Vectors And Plasmid DNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Viral Vectors And Plasmid DNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Viral Vectors And Plasmid DNA Market

• 21.1. Eastern Europe Viral Vectors And Plasmid DNA Market Overview
• 21.2. Eastern Europe Viral Vectors And Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Viral Vectors And Plasmid DNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Viral Vectors And Plasmid DNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Viral Vectors And Plasmid DNA Market

• 22.1. Russia Viral Vectors And Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Viral Vectors And Plasmid DNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Viral Vectors And Plasmid DNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Viral Vectors And Plasmid DNA Market

• 23.1. North America Viral Vectors And Plasmid DNA Market Overview
• 23.2. North America Viral Vectors And Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Viral Vectors And Plasmid DNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Viral Vectors And Plasmid DNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Viral Vectors And Plasmid DNA Market

• 24.1. USA Viral Vectors And Plasmid DNA Market Overview
• 24.2. USA Viral Vectors And Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Viral Vectors And Plasmid DNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Viral Vectors And Plasmid DNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Viral Vectors And Plasmid DNA Market

• 25.1. Canada Viral Vectors And Plasmid DNA Market Overview
• 25.2. Canada Viral Vectors And Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Viral Vectors And Plasmid DNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Viral Vectors And Plasmid DNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Viral Vectors And Plasmid DNA Market

• 26.1. South America Viral Vectors And Plasmid DNA Market Overview
• 26.2. South America Viral Vectors And Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Viral Vectors And Plasmid DNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Viral Vectors And Plasmid DNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Viral Vectors And Plasmid DNA Market

• 27.1. Brazil Viral Vectors And Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Viral Vectors And Plasmid DNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Viral Vectors And Plasmid DNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Viral Vectors And Plasmid DNA Market

• 28.1. Middle East Viral Vectors And Plasmid DNA Market Overview
• 28.2. Middle East Viral Vectors And Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Viral Vectors And Plasmid DNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Viral Vectors And Plasmid DNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Viral Vectors And Plasmid DNA Market

• 29.1. Africa Viral Vectors And Plasmid DNA Market Overview
• 29.2. Africa Viral Vectors And Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Viral Vectors And Plasmid DNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Viral Vectors And Plasmid DNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Viral Vectors And Plasmid DNA Market Competitive Landscape And Company Profiles

• 30.1. Viral Vectors And Plasmid DNA Market Competitive Landscape
• 30.2. Viral Vectors And Plasmid DNA Market Company Profiles
  • 30.2.1. FUJIFILM Diosynth Biotechnologies
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. FinVector Vision Therapies
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Lonza Group AG
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Cobra Biologics and Pharmaceutical Services
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Brammer Bio
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Viral Vectors And Plasmid DNA Market Competitive Benchmarking

32. Global Viral Vectors And Plasmid DNA Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Viral Vectors And Plasmid DNA Market

34. Viral Vectors And Plasmid DNA Market Future Outlook and Potential Analysis

• 34.1 Viral Vectors And Plasmid DNA Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Viral Vectors And Plasmid DNA Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Viral Vectors And Plasmid DNA Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer